Yasser Perera

This study evaluates two synthetic adjuvants, ODN-39M and LALF32-51, for enhancing immune response against Mycobacterium tuberculosis Ag85B via nasal vaccination in mice, showing ODN-39M's effectiveness in inducing Th1 and mucosal immunity.

This study evaluates two nasal coronavirus vaccines in African Green Monkeys, showing they induce cross-reactive immunity and neutralizing responses against SARS-CoV-2 and related coronaviruses.

This paper evaluates a nasal SARS-CoV-2 vaccine candidate based on S2 and N proteins, showing broad antibody responses and mucosal immunity in mice.

This study examines the time- and dose-dependent effects of CIGB-300 on the proteome of squamous lung cancer cells, identifying potential biomarkers and mechanisms of action.

This study shows that CIGB-300 reverses multidrug resistance in ABCB1-overexpressing lung cancer cells by inhibiting ABCB1 expression and related signaling pathways.

This study uses computational biology to investigate how CIGB-300, a CK2 kinase antagonist, may interfere with SARS-CoV-2 infection and related pathologies.